Viatris

VTRS · United States · Pharmaceuticals · matched S&P 500 member. Follow its market-weight contribution.

Historical time machine

Historical observation

20182026

Universe weight

0.034%

12M weight contribution

-0.011 pp

3M weight contribution

-0.007 pp

12M price return

-12.7%

Share of matched S&P 500 members

Monthly observations through Nov 2023

Company price index

A separate dimension from market allocation

Historical observations

Most recent 24 observations at or before the selected month

Month	Market cap	Universe weight	12M weight change	12M return	Above 6M weight average
Nov 2023	$11.0bn	0.034%	-0.011 pp	-12.7%	No
Oct 2023	$10.7bn	0.036%	-0.007 pp	-8.0%	Yes
Sep 2023	$11.8bn	0.039%	-0.001 pp	+21.1%	Yes
Aug 2023	$12.9bn	0.041%	-0.000 pp	+17.8%	Yes
Jul 2023	$12.6bn	0.028%	-0.013 pp	+13.8%	No
Jun 2023	$12.0bn	0.028%	-0.022 pp	-0.1%	No
May 2023	$11.0bn	0.027%	-0.026 pp	-21.9%	No
Apr 2023	$11.2bn	0.038%	-0.007 pp	-5.6%	No
Mar 2023	$11.5bn	0.039%	-0.005 pp	-7.6%	No
Feb 2023	$13.6bn	0.048%	+0.002 pp	+7.0%	Yes
Jan 2023	$14.7bn	0.050%	-0.010 pp	-15.4%	Yes
Dec 2022	$13.5bn	0.049%	-0.004 pp	-14.3%	Yes
Nov 2022	$13.4bn	0.045%	-0.005 pp	-6.6%	Yes
Oct 2022	$12.3bn	0.044%	-0.010 pp	-21.1%	No
Sep 2022	$10.3bn	0.041%	-0.017 pp	-34.6%	No
Aug 2022	$11.6bn	0.041%	-0.018 pp	-32.2%	No
Jul 2022	$11.7bn	0.040%	-0.018 pp	-28.7%	No
Jun 2022	$12.7bn	0.049%	-0.012 pp	-24.2%	No
May 2022	$14.9bn	0.054%	-0.012 pp	-16.7%	Yes
Apr 2022	$12.5bn	0.045%	-0.013 pp	-19.9%	No
Mar 2022	$13.2bn	0.044%	+0.011 pp	-19.6%	No
Feb 2022	$13.3bn	0.046%	+0.046 pp	-23.5%	No
Jan 2022	$18.1bn	0.061%	+0.061 pp	-9.8%	Yes
Dec 2021	$16.4bn	0.052%	+0.052 pp	-26.1%	No

Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.